BMRN vs CRNX
BioMarin Pharmaceutical Inc. · Crinetics Pharmaceuticals, Inc.
Relative return (rebased to 100)
Key stats
| Metric | BMRN | CRNX |
|---|---|---|
| Price | $62.21 | $84.95 |
| Market Cap | $12.04B | $9.01B |
| P/E | 34.51 | — |
| P/B | 1.90 | 7.56 |
| P/S | 3.74 | 1170.77 |
| ROE | 5.5% | -39.0% |
| Net Margin | 10.8% | -6046.2% |
| Gross Margin | — | — |
| Revenue Growth | 12.9% | 640.7% |
| Dividend Yield | — | — |
| EPS | $1.80 | -$4.39 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.